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Aim: The main goal of this investigation was to evaluate the inﬂuence of positive Staphylo-
coccus aureus culture from the genital tract on patients receiving radiation therapy, suffering
from  carcinoma of the uterus. The other aim was to observe radiation therapy complications.
Background: Radiation therapy of patients suffering from cervical cancer can be connected
with inﬂammation of the genitourinary tract.
Materials and methods: In years 2006–2010 vaginal swabs from 452 patients were examined.
39  women with positive S. aureus cultures were analysed.
Results: Complications and interruptions during radiation therapy were observed in 7 (18.9%)
of  37 patients with positive vaginal S. aureus culture. One of them, a 46-year-old woman
developed pelvic inﬂammatory disease. None of the six patients who received palliative
radiotherapy showed interruption in this treatment. Isolated S. aureus strains were classiﬁed
into 13 sensitivity patterns, of which 8 were represented by 1 strain, two  by 2 strains and
three by 13, 8 and 6 strains. One strain was diagnosed as methicillin resistant S. aureus
(MRSA).
Conclusions: The results of the present study show that S. aureus may generally be isolated
from the genital tract of female patients with neoplastic disease of uterus but is not oftenobserved as inﬂammation factor of this tract. Comparison of species’ resistance patterns
may be used in epidemiological studies in order to discover the source of infections and
therefore be of profound signiﬁcance in the prevention of nosocomial infections.
©  2012 Greater Poland Cancer Centre. Published by Elsevier Urban & Partner Sp. z.o.o. All
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tract.1 There are a few papers describing the presence of
2the world literature shows that S. aureus is one of the main
pathogens responsible for a number of infections in hospital
wards with considerable morbidity and mortality.3–5
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Table 1 – Sensitivity of S. aureus isolated from vaginal
swabs.
The name of
drug
The number of strains
Sensitive Intermediately
sensitive
Resistant
Penicillin 12 0 27
Oxacillin 38 0 1
Erythromycin 25 9 5
Clindamycin 38 0 1
Gentamicin 38 0 1
Norﬂoxacin 37 2 0
Levoﬂoxacin 39 0 0
Vancomycin 39 0 0
Teicoplanin 39 0 0
Tetracyclin 33 0 6
Minocyclin 38 0 1
Cotrimoxazole 35 0 4
Fusidic acid 39 0 0
Rifampicin 39 0 0
Nitrofurantoin 39 0 0
Quinupristin/ 39 0 0208  reports of practical oncology an
The Staphylococcus and Micrococcus are genera belonging
to the family Micrococcaceae.
Only one species, S. aureus,  is an important primary
pathogen. The other staphylococci lack primary pathogenic-
ity and are reported to the physician as coagulase negative
staphylococci (CNS).
The main site of S. aureus in humans is the nasal cavity.
Nasal carriers in the general population can be divided into
two groups: persistent carriers (20–30% of the population yield
S. aureus from the nasal cavity at all times) and intermittent
carriers (20–30% carry S. aureus for a few days or weeks). The
remaining part of the population is noncarriers.6
The aim of bacteriological examination is to determine
whether S. aureus was the causative agent of infection and
what antimicrobial drugs can be used for treatment.
2.  Aim
The main goal of this investigation was to evaluate the inﬂu-
ence of positive S. aureus culture from the genital tract on
patients receiving radiation therapy, suffering from carcinoma
of the uterus. The other aim was to observe radiation therapy
complications.
3.  Materials  and  methods
Microbiological examinations of the genital tract in patients
suffering from colli uteri carcinoma were introduced as a
standard method in the Department of Radiotherapy and
Gynaecological Oncology at the Greater Poland Cancer Cen-
tre. In the years 2006–2010 vaginal swabs from 452 patients
were examined. 39 women with positive S. aureus cultures
were analysed. 37 of them were diagnosed with colli uteri
carcinoma of IIB to IVA degree according to the FIGO clinical
classiﬁcation: 6 patients with IIB degree, 1 with IIA, 25 with
IIB, 5 with IVA. One of these patients was treated because
of metastases from renal carcinoma to vagina and another
one because of corpus uteri carcinoma with inﬁltration to colli
uteri. In all cases clinical ﬁndings agreed with histopatholog-
ical diagnosis.
The age of the patients was from 38 to 83 years, 56 years at
average.
Among 37 patients with cervical cancer 31 (83.8%) received
radical radiotherapy which consisted of external beam radio-
therapy combined with intracavitary brachytherapy.
Conformal radiotherapy was administered with 15 MV  pho-
tons, using a conventional 4-ﬁeld box technique (opposing
anterior and posterior ﬁelds, and two opposing lateral ﬁelds).
Clinical treatment volume covered tumour of the vagi-
nal fornix and walls, parametria and pelvic lymph nodes.
Teletherapy was combined with high-dose brachytherapy
(HDR) delivered with anatomy-adjusted applicators (tubes,
ovoids, cylinders and needles). The patients were given four
fractions of treatment. In the group of radically treated women
25 received concurrent chemotherapy (radiochemotherapy) –
cisplatin 40 mg/m2 given on a weekly basis (5–6 administra-
tions).
Due to advanced stage of cervical neoplastic disease six
patients (16.2%) were qualiﬁed for a shortened, palliativedalfopristin
irradiation of the pelvis with the use of two  AP-PA opposing
beams technique to be given in one or two series.
The vaginal swabs were cultured on the following microbi-
ological media: blood agar, selective media for Gram-negative
bacilli, chromagar for yeasts, coccosel agar, cetrimide agar,
broth medium. The identiﬁcation of microorganisms was per-
formed according to standard bacteriological methods, the API
20 identiﬁcation system (bioMérieux, Marcy l’Etoile, France)
was used for conﬁrmation. Antibiotic sensitivity was assessed
using the ATB system.
4.  Results
Results of 39 isolated S. aureus sensitivity tests are presented in
Tables 1 and 2. All strains were sensitive to levoﬂoxacin, van-
comycin, teicoplanin, fusidic acid, rifampicin, nitrofurantoin
and quinupristin/dalfopristin – Table 1. As shown in Table 2,
S. aureus strains were classiﬁed into 13 sensitivity patterns,
of which 8 were represented by 1 strain, two – by 2 strains
and three by 13, 8 and 6 strains. One strain was diagnosed as
methicillin resistant S. aureus (MRSA) with sensitivity pattern
number 13: 0002222220202222 (Table 2).
Complications and interruptions during radiation therapy
were observed in 7 (18.9%) of 37 patients with positive vagi-
nal S. aureus culture. Two of them developed urinary tract
infection. Enterococcus faecalis and Staphylococcus epidermidis
were isolated from urine cultures of these patients. Pelvic
inﬂammatory disease was observed in one of the 7 patients, a
46-year-old women with third degree inﬂammation according
to the CTC (Common Terminology Criteria for Adverse Events-
version 4.0) classiﬁcation. Clinical symptoms were as follows:
temperature from 38 ◦C to 39.6 ◦C, abdominal pain, purulent
malodorous discharge from the genital tract. Cervical swab
culture showed the growth of S. aureus with sensitivity pattern
number 3: 0212222222222222 (Table 2) and S. dysgalactiae ssp.
equisimilis sensitive to beta lactam antibiotics, glycopeptides,
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Table 2 – Sensitivity patterns of isolated S. aureus strains.
Pattern Antibiotic No. of strains
A B C D E F G H I J K L M N O P
1 0 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 13
2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 8
3 0 2 1 2 2 2 2 2 2 2 2 2 2 2 2 2 6
4 0 2 2 2 2 2 2 2 2 0 2 2 2 2 2 2 2
5 2 2 0 2 2 2 2 2 2 2 2 2 2 2 2 2 2
6 0 2 1 2 2 2 2 2 2 0 2 2 2 2 2 2 1
7 2 2 2 2 2 2 2 2 2 2 2 0 2 2 2 2 1
8 2 2 1 2 2 2 2 2 2 2 2 2 2 2 2 2 1
9 0 2 2 2 2 1 2 2 2 2 2 2 2 2 2 2 1
10 0 2 0 2 2 2 2 2 2 2 2 2 2 2 2 2 1
11 0 2 1 2 2 2 2 2 2 0 2 0 2 2 2 2 1
12 0 2 0 0 0 1 2 2 2 0 0 0 2 2 2 2 1
13 0 0 0 2 2 2 2 2 2 0 2 0 2 2 2 2 1
A: penicillin; B: oxacillin; C: erythromycin; D: clindamycin; E: gentamicin; F: norﬂoxacin; G: levoﬂoxacin; H: vancomycin; I: teicoplanin; J: tetra-
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scycline; K: minocycline; L: cotrimoxazole; M: fusidic acid; N: rifampic
2: Sensitive; 1: intermediately sensitive; 0: resistant.
evoﬂoxacin and clindamycin. The patient was treated accord-
ng to the sensitivity test of isolated strains.
Three other patients developed vaginitis and collitis – sec-
nd degree inﬂammation according to the CTC classiﬁcation.
aginal swab culture of two patients showed the growth of
. aureus with sensitivity pattern number 1, and number 10
n one patient (Table 2). All of these patients received local
reatment. One of the 7 patients who had interruptions during
adiation therapy suffered from neutropenia which developed
s a complication of complex carcinoma treatment.
None of the six patients who received palliative radiother-
py showed interruption in this treatment.
. Discussion
solated S. aureus strains showed high sensitivity to antibiotics.
7 of 39 strains were resistant to 1 or 2 antibiotics from the 16
sed for sensitivity tests and 8 strains were sensitive to all of
hese antibiotics, see Table 2. On the other hand, one strain
solated on 15.03.2008 showed resistance to 6 antibiotics and
nother one isolated on 18.12.2007 was MRSA. It should be
tressed that isolated MRSA was sensitive to vancomycin rec-
mmended for treatment of septic patients and to rifampicin
nd fusidic acid which are used for eradication of MRSA in
arriers in some countries, for example in Denmark. The infec-
ions caused by MRSA are particularly dangerous because of
ery high resistance of these bacteria to antibiotics. According
o Branger et al., MRSA strains isolated in France were clas-
iﬁed into two basic zymotypes while strains isolated in the
SA were more  diversiﬁed.7 Diversiﬁed clones of MRSA were
bserved in Germany, as well.8
The production of beta lactamases is responsible for high
roportion of strains resistant to penicillin which were not
lassiﬁed as MRSA. As shown in Table 1, only 12 of 39 strains
ere sensitive to penicillin. Soon after penicillin became a
rincipal drug in treatment of staphylococcal infections an
ncrease of penicillin resistance was observed, particularly
mong hospital-associated strains. Zierdt et al. found S. aureus
trains which produced a particularly high amount of beta nitrofurantoin; P: quinupristin/dalfopristin.
lactamases: HBLPSA (hyper beta-lactamase producing S.
aureus). Oxacillin resistance of HBLPSA is neutralised in the
presence of clavulanic acid.8
Most penicilinase-releasing strains are sensitive to methi-
cillin, ﬂucloxacillin, ampicillin, vancomycin, teicoplanin,
cotrimoxazol, amoxycillin plus clavulanic acid.
Some penicillin-resistant strains are also resistant to
methicillin. Methicillin resistant strains S. aureus (MRSA) have
become the case of the most serious nosocomial infections in a
number of hospitals. Carriers of S. aureus may develop a noso-
comial infection and this species is one of the most frequently
observed form of the infection.9
The mechanism of resistance to methicillin is related to
an alteration in penicillin binding proteins (PBP) produced
by resistant strains leading to the development of multidrug
resistant S. aureus.  Chromosomal gene mec A is responsible for
the presence of a novel PBP in the bacterial membrane.6 We
found one MRSA strain isolated from a patient suffering from
cervix cancer. It is worth noting that this strain did not spread
in our Department of Radiotherapy and Gynaecologic Oncol-
ogy. No other patients were infected with MRSA between 2006
and 2010.
In epidemiological studies, aimed at ﬁnding the sources of
nosocomial infections, it is important to identify the bacte-
rial species involved. One of the methods used to differentiate
bacterial species is to determine their sensitivity to drugs. Cor-
rect etiological diagnosis and appropriate treatment can have
the effect of reducing the numbers of nosocomial infections.
Conﬁrmed radiotherapy of our patients was administered
with 15MV photons. According to Tyagi et al., intensity modu-
lated radiotherapy (IMRT) generated by 15 MV  photon energies
was used for treatment carcinoma of cervix, as well.10
6.  ConclusionThe results of the present study show that S. aureus may gen-
erally be isolated from the genital tract of female patients with
neoplastic disease of the utreus but is not often observed as
inﬂammation factor of this tract.
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Comparison of species’ resistance patterns may be used
in epidemiological studies in order to discover the source of
infections and therefore be of profound signiﬁcance in the
prevention of nosocomial infections.
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